MATTHEW THORNTON: Open Payments
NPI 1437801305 · ETOWAH, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,366 in 83 payments from 19 companies in 2025. Trend: 2023 $591 · 2024 $681 · 2025 $1,366
Food & beverage: $1,366
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $233 |
| Novo Nordisk Inc | 9 | $171 |
| Lilly USA, LLC | 12 | $156 |
| Amgen Inc. | 12 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $106 |
| Medtronic, Inc. | 5 | $91 |
| Esperion Therapeutics, Inc. | 5 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| PFIZER INC. | 3 | $50 |
Products named: VRAYLAR, OTEZLA, Kerendia, MINIMED 780G, MOUNJARO, JARDIANCE, NEXLETOL, XIFAXAN.
Industry payments across TN — which companies pay providers there.
